Expression of Fascin on human early-stage non-small-cell lung cancer tissue and its clinical characteristics

VernacularTitle:Fascin 蛋白在早期非小细胞肺癌中的表达及其临床意义
Author: Tiepeng HAN ; Lei YANG ; Jinjing TAN ; Meng GU ; Yue WANG ; Zitong WANG ; Wentao YUE
Keywords: Fascin; Carcinoma,non-small-cell lung; Immunohistochemistry; Prognosis
From: Chinese Journal of Thoracic and Cardiovascular Surgery 2017;33(1):36-40
CountryChina
Language:Chinese
Abstract: Objective To investigate the expression of Fascin in early-stage NSCLC, evaluate the relevance between Fascin expression level and prognosis.Methods The immunohistochemistry method was used to assess the expression of Fas-cin in 111 lung cancer FFPE tissues with stage Ⅰ and Ⅱ NSCLC.The relationship between Fascin expression and the clinico-pathological characteristics was analyzed.The prognostic significance of Fascin expression was evaluated with Kaplan-Meier sur-vival analysis.Results In the early-stage of NSCLC, the positive rate of Fascin expression was 64.8%, no expression in the paracarcinoma tissue.The positive rate of squamous cell carcinoma was 78.7% and was significantly higher than that in adeno-carcinoma 48.0%(P<0.01).Whether in squamous cell carcinoma or adenocarcinoma group, the expression of Fascin was correlated significantly with lymph node metastasis tumor stages and DFS(P<0.05).And the positive expression of Fascin was an independent risk factor of poor prognosis for patient with NSCLC .Conclusion Fascin is expected to be a biomarker for the prognosis of patients with early-stage NSCLC.